Vedanta gets rights to JSR's microbiome-derived immunotherapies

Vedanta Biosciences Inc. (Boston, Mass.) received exclusive rights to a microbiome cocktail and related technology from JSR Corp. (Tokyo:4185), which Vedanta will use

Read the full 231 word article

User Sign In